Press Releases
<< Back
Horizon Technology Finance Provides Third Quarter 2019 Portfolio Update
"The momentum in the venture debt market we experienced during the first half of 2019 continued into the third quarter, as we successfully grew our portfolio for a sixth consecutive quarter by originating
Originations
Horizon funded six loans during the third quarter of 2019 totaling
$20.0 million to a new portfolio company,CVRx, Inc. , a developer of a premarketFDA -approved medical device addressing advanced cardiovascular diseases.$11.6 million to an existing portfolio company,MacuLogix, Inc. , a medical device company in the optometry and ophthalmology industry.$5.0 million to a new portfolio company,LogicBio Therapeutics, Inc. , (NASDAQ: LOGC), a genome editing company focused on developing medicines to durably treat rare diseases.$4.8 million to an existing portfolio company focused on the late-stage development and commercialization of drugs to treat cardiovascular diseases.$2.7 million to an existing portfolio company,IntelePeer Holdings, Inc. , a leading provider of business communications.$2.5 million to an existing portfolio company,Bridge2 Solutions, LLC , a SaaS platform technology company providing innovative solutions to drive engagement and loyalty between brands and their consumers.
Liquidity Events
Horizon experienced liquidity events from three portfolio companies in the third quarter of 2019, encompassing outstanding principal prepayments of
- In September,
Catasys, Inc. ("Catasys ") prepaid its outstanding principal balance of$15.0 million on its venture loan, plus interest, end-of-term payment, prepayment fee and a revenue-based payment. Horizon continues to hold warrants inCatasys . - In September,
Food52 Inc. ("Food52") prepaid its outstanding principal balance of$6.0 million on its venture loan, plus interest, end-of-term payment and prepayment fee. Horizon will also receive proceeds of$500,000 from the termination of its warrants in Food52. - In September, with the proceeds of a new loan from Horizon,
MacuLogix, Inc. ("MacuLogix") prepaid its previously outstanding principal balance of$7.5 million on its venture loan, plus interest and end-of-term payment. Horizon continues to hold warrants in MacuLogix.
Joint Venture Activity
During the third quarter of 2019, Horizon transferred
Principal Payments Received
During the third quarter of 2019, Horizon received regularly scheduled principal payments on investments totaling
Commitments
During the third quarter ended
Pipeline
As of
Capital Markets Activity, Warrant and Equity Portfolio
As of
About
Forward-Looking Statements
Statements included herein may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in Horizon's filings with the
Contacts:
Investor Relations:
ICR
ir@horizontechfinance.com
(860) 284-6450
Media Relations:
ICR
brian.ruby@icrinc.com
(203) 682-8268
View original content:http://www.prnewswire.com/news-releases/horizon-technology-finance-provides-third-quarter-2019-portfolio-update-300934853.html
SOURCE